Cargando…
Can we cure stage IV triple-negative breast carcinoma?: Another case report of long-term survival (7 years)
RATIONALE: Triple-negative breast cancer has a dismal prognosis, especially once it has spread to other organs, due to the lack of effective treatments available at this time. Finding an effective treatment for metastatic triple-negative breast cancer remains an unmet medical need. PATIENT CONCERNS:...
Autores principales: | Chue, Ben Man-Fai, La Course, Bryce Douglas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756617/ https://www.ncbi.nlm.nih.gov/pubmed/31567994 http://dx.doi.org/10.1097/MD.0000000000017251 |
Ejemplares similares
-
Case report of long-term survival with metastatic triple-negative breast carcinoma: Treatment possibilities for metastatic disease
por: Chue, Ben Man-Fai, et al.
Publicado: (2019) -
Prognostic value of IMP3 immunohistochemical expression in triple negative breast cancer
por: Sjekloča, Nikoleta, et al.
Publicado: (2020) -
MicroRNAs in the prognosis of triple-negative breast cancer: A systematic review and meta-analysis
por: Lü, Lingshuang, et al.
Publicado: (2017) -
Features of triple-negative breast cancer: Analysis of 38,813 cases from the national cancer database
por: Plasilova, Magdalena L., et al.
Publicado: (2016) -
High expression of MORC2 predicts worse neoadjuvant chemotherapy efficacy in triple negative breast cancer
por: Liao, Xiaohong, et al.
Publicado: (2023)